Highest risk seen for those with both physical frailty and depression; significant additive interaction also seen.

Cribriform-negative disease had a low metastasis rate unaffected by treatment. After radiation therapy with neoadjuvant ADT group, men with cribriform-positive disease had the same metastasis rate as ...

Lower risk for foot disease driven by lower risk for neuropathy for new users of SGLT-2 inhibitors versus GLP-1 receptor agonists.

Phase 3 trial data show subcutaneous anifrolumab improves BICLA response rates and reduces oral corticosteroid use in systemic lupus erythematosus.

(HealthDay News) — Financial strain and food insecurity are drivers of accelerated biological heart aging, according to a study published in the December issue of the Mayo Clinical Proceedings.